• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides

Recent Advances in the Study of N,N-Diethyl 3-bromo-5-trifluoromethylbenzenesulfonamide (CAS: 951885-25-9)

N,N-Diethyl 3-bromo-5-trifluoromethylbenzenesulfonamide (CAS: 951885-25-9) has emerged as a compound of significant interest in the field of chemical biology and medicinal chemistry. Recent studies have focused on its synthesis, structural characterization, and potential applications in drug discovery and development. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical properties, biological activities, and therapeutic potential.

The synthesis of N,N-Diethyl 3-bromo-5-trifluoromethylbenzenesulfonamide has been optimized in recent studies, with a focus on improving yield and purity. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound. These studies have confirmed the structural integrity of the molecule and provided insights into its stability under various conditions.

In terms of biological activity, N,N-Diethyl 3-bromo-5-trifluoromethylbenzenesulfonamide has shown promising results in preliminary screening assays. Researchers have investigated its potential as an inhibitor of specific enzymes involved in inflammatory pathways. The compound's unique structural features, including the trifluoromethyl and bromo substituents, are believed to contribute to its binding affinity and selectivity. Further in vitro and in vivo studies are underway to elucidate its mechanism of action and evaluate its efficacy in disease models.

Recent publications have also explored the potential of N,N-Diethyl 3-bromo-5-trifluoromethylbenzenesulfonamide as a building block for the development of more complex therapeutic agents. Its sulfonamide moiety, in particular, has been leveraged to design derivatives with enhanced pharmacokinetic properties. Computational modeling and structure-activity relationship (SAR) studies have provided valuable insights into the optimization of these derivatives for specific biological targets.

Despite these advancements, challenges remain in the development of N,N-Diethyl 3-bromo-5-trifluoromethylbenzenesulfonamide-based therapeutics. Issues such as solubility, bioavailability, and potential off-target effects need to be addressed in future research. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to overcome these hurdles and translate the compound's potential into clinical applications.

In conclusion, N,N-Diethyl 3-bromo-5-trifluoromethylbenzenesulfonamide (CAS: 951885-25-9) represents a promising candidate for further investigation in the field of medicinal chemistry. Its unique chemical structure and preliminary biological activities warrant continued research to fully explore its therapeutic potential. Future studies should focus on optimizing its properties and evaluating its safety and efficacy in relevant disease models.

• 957062-78-1(N,N-Dipropyl 3-bromo-5-trifluoromethylbenzenesulfonamide)
• 951884-67-6(3-Bromo-N-propyl-5-(trifluoromethyl)benzenesulfonamide)
• 951884-69-8(1-(3-Bromo-5-trifluoromethylphenylsulfonyl)piperidine)
• 951884-61-0(N-Cyclopropyl 3-bromo-5-trifluoromethylbenzenesulfonamide)
• 97630-12-1(1-[3,5-bis(trifluoromethyl)phenyl]sulfonylpiperazine;hydrochloride)
• 850429-71-9(N,N-Diethyl 3-bromo-4-methylbenzenesulfonamide)
• 793679-07-9(1-4-(Trifluoromethyl)benzenesulfonylpiperazine)
• 1020252-83-8(N-Butyl 3-bromo-5-(trifluoromethyl)benzenesulfonamide)
• 1020253-03-5(N,N-Diethyl 4-bromo-3-trifluoromethylbenzenesulfonamide)
• 939989-87-4(4-Bromo-N,N-dimethyl-3-(trifluoromethyl)benzenesulfonamide)